SECURITY LEVEL: UNRESTRICTED INSTITUTIONAL / ENGINE HASH: ecff4d65...5cd1
SAMPLE MODE · INDONESIA SPECIMEN
AseanPrimer Logo ASEANPRIMER
Concierge Desk
Interactive Underwriting Sample · Indonesia Specimen

Indonesia: Healthcare Licensing & Facility Registers

Demonstrating how differences between corporate records, OSS-RBA licensing data, and facility-specific healthcare authorisations identify specific matters requiring verification before the target's authorised operating scope is confirmed.

Illustrative scenario only. No live VDR data ingested.
Core Underwriting Pipeline Walkthrough
01 / TRIGGER Regulatory Question
02 / EVIDENCE Applicability & Records
03 / ATTRIBUTION Conditional Financial Assumption
04 / DECISION Targeted RFI & Model Gate
01 — REGULATORY QUESTION APPLICABILITY & EVIDENCE SCOPE

Do the target's current facility-level business licences and healthcare-sector approvals fully substantiate the specialized clinical services contributing to projected expansion revenues?

Primary Regulatory References:
02 — EVIDENCE STATUS MISSING

Facility-level healthcare authorisations incomplete

Illustrative evidence profile: The scenario assumes an acquisition of a private hospital and clinical operator in West Java, but specific operational facility approvals have not been verified in the transaction records:

  • • Current facility-level business licences and healthcare-sector approvals applicable to the hospital, clinic and relevant specialized services, including any required approvals for the expanded clinical activities: MISSING
  • • Reconciliation of the target's registered business activities under the applicable KBLI classification with the actual clinical services provided at each relevant facility: MISSING
  • • Environmental, building, and operational safety authorisations applicable to the relevant site and specialized inpatient units: MISSING

Analyst note: Differences between corporate registry entries (NIB/KBLI) and specialized healthcare facility authorisations require verification before confirming operating scope. The absence of a branch-specific permit in the data room does not establish statutory non-compliance or operating illegality, but prevents confirming that the facility's full scope of services is documented.

03 — UNDERWRITING CONSEQUENCE CONDITIONAL

Revenue assumptions tied to unevidenced services remain conditional

Hypothetical Deal Model Context (Fictional Example)

The target's investment model projects annual specialized outpatient and surgical clinic revenue of IDR 14.5 billion / year attributable to newly expanded operating units.

Underwriting Determination:

The projected IDR 14.5 billion annual revenue assumption remains unverified to the extent it depends on the outstanding authorisation evidence. It is neither accepted as fully substantiated nor automatically reduced to zero. The baseline financial valuation of compliant core healthcare activities is retained, and only the unverified expansion assumption remains unresolved pending documentary review.

  • • No automatic valuation haircut or balance-sheet write-down is imposed.
  • • No arbitrary revenue deduction is introduced for compliant core hospital operations.
  • • The documented financial baseline of general healthcare operations is maintained.
  • • The underwriting condition is strictly confined to the IDR 14.5 billion revenue line dependent on the specific unevidenced clinical authorisations.
04 — REQUIRED EVIDENCE AND NEXT ACTION TARGETED RFI

Targeted request for information (RFI)

  • • Request the current NIB and relevant OSS-RBA records, current facility-level business licences, and applicable healthcare-sector approvals.
  • • Obtain the documentary reconciliation between registered KBLI activities and the actual clinical services provided at each facility.
  • • Review inspection reports, building approvals, or correspondence issued by the competent health authority regarding branch expansion approvals.
  • • Reassess the IDR 14.5 billion revenue assumption against the verified authorisations and service-to-revenue mapping. Determine whether any corrective filing, licence amendment or other transaction protection is necessary only if the evidence establishes a material gap.

Transaction response: Any proposed condition precedent (CP), operating covenant, or indemnity protection should follow the verified evidence, materiality, and the required timeline for administrative regularisation.

UNDERWRITING OUTPUT EXECUTIVE DELIVERABLE SUMMARY
Financial assumption affected: Projected specialized clinical expansion revenue of IDR 14.5 billion / year and related operating margin.
Current underwriting status: CONDITIONAL — illustrative records do not yet confirm facility-level operating approvals for the specialized expansion units.
Evidence required to resolve: Current facility-level business licences, applicable healthcare-sector approvals, and service-to-revenue mapping confirming authorized treatment scope.
Next transaction decision: Retain the documented core healthcare baseline. Reassess the projected IDR 14.5 billion annual expansion revenue after reviewing the relevant facility-level licences, applicable healthcare-sector approvals, and service-to-revenue mapping. Recognise only the revenue assumptions supported by that review.
Scope limitation: No finding of regulatory breach, facility closure, or valuation adjustment is presumed on the evidence currently specified.
Transaction Advisory Desk

Have an Indonesia transaction question requiring this level of scrutiny?

Submit an unresolved regulatory dependency or valuation assumption for initial screening. Confidential VDR documents are not required for the initial screen.

Submit a Transaction Question →
Illustrative scenario only. This page demonstrates the decision framework; it does not represent a live transaction review or legal opinion.